Building a Home for Health Equity
The laboratory’s role in reaching underserved patient populations: an interview with Richard Levenson, Keisuke Nakagawa, and Michele Mitchell
The laboratory’s role in reaching underserved patient populations: an interview with Richard Levenson, Keisuke Nakagawa, and Michele Mitchell
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
Free open-source software can be leveraged across diagnostic processes—how can your organization benefit from it?
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.
New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.
The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.